Abstract
Metabolic syndrome (MS) can increase an individual's chances of developing diabetes, cardiovascular, and neurodegenerative diseases. Therefore, studies showing possible therapies for MS are necessary. Among these, there is supplementation with beta-alanine (BA), a promising substance in reducing the amount of free radicals present in an organism with MS. Thus, the aim of this study will b…